The cumulative number of variants from CYP1A1 and CYP1A2 was in fact associated with a significant risk for lung cancer in ever smokers and a protective effect in never smokers, with a highly significant smoking-genotype interaction. Here, CYP1A2 is linked to lung carcinoma.